In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product ...

Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced two new developments for its ...

Quest Diagnostics has introduced a new flow cytometry measurable residual disease (MRD) blood test for myeloma, a cancer arising from abnormal plasma cells. The test aims to enhance ultra-sensitive ...

Quest Diagnostics launched a direct-to-consumer service that allows users to order and pay for lab tests from home. Dubbed QuestDirect, the online service offers 35 diagnostic test packages covering ...

Quest Health’s tests may provide a convenient and accessible way for someone to gain insight into their health without needing to visit a doctor. They may also be beneficial for those who require ...

Quest Diagnostics is launching what it dubs a “disruptive” nationwide ad and marketing campaign aimed at getting consumers “to take action on their health” and sign up for a host of the medtech ...

Quest Diagnostics has a strong Q2 with a slight beat on EPS and revenue. Quest’s base business appears to be recovering from the pandemic and pulled in $2.30B in revenue. Despite fading COVID-related ...

Quest Diagnostics recently unveiled a suite of advanced diagnostics and support services designed to broaden access to lab tests for transplants. Quest hopes to improve testing compliance among ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...